CME Group

CME · NASDAQ · USD

$263.14−0.74%−$1.96

Close · October 2, 2026

At a glance

Revenue growth: +6.32%; 2025 vs 2024
Net income growth: +15.50%; 2025 vs 2024
Net margin: 62.6%; 2024: 57.6%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	1,702	1,876	1,644	1,534	1,689	1,639	1,523	1,582	1,530	1,486	1,437	1,335
Cost of revenue	234	223	241	238	222	—	—	—	—	—	—	—
Gross profit	1,702	1,876	1,644	1,534	1,689	1,639	1,523	1,582	1,530	1,486	1,437	1,335
Selling, general and administrative	469	447	473	440	430	407	417	427	403	400	401	387
Operating income	1,107	1,310	1,049	973	1,129	1,108	952	1,024	1,001	960	886	820
EBIT	1,107	1,310	1,049	973	1,129	1,108	952	1,024	1,001	960	886	820
EBITDA	1,191	1,393	1,132	1,055	1,213	1,191	1,036	1,108	1,085	1,045	972	909
Interest expense	43.6	43.6	43.7	44.0	44.0	41.7	40.7	40.2	40.1	39.9	39.7	39.6
Pre-tax income	1,328	1,511	1,578	1,177	1,330	1,245	1,097	1,177	1,155	1,113	1,006	974
Income tax	286	357	396	269	305	289	222	264	271	258	191	224
Net income	1,042	1,154	1,183	908	1,025	956	875	913	883	855	815	750
Net income to common shareholders	1,042	1,159	1,168	897	1,012	944	864	901	872	844	804	741
Basic EPS	2.89	3.22	3.25	2.49	2.81	2.63	2.40	2.51	2.43	2.35	2.24	2.06
Diluted EPS	2.88	3.18	3.24	2.49	2.81	2.62	2.40	2.50	2.42	2.35	2.24	2.06
Average shares (basic)	361	359	360	360	360	360	360	359	359	359	359	359
Average shares (diluted)	361	363	360	360	360	360	360	360	360	360	360	360
Dividend per share	1.30	1.30	1.25	1.25	1.25	1.25	1.15	1.15	1.15	1.15	1.10	1.10